Japanese Licensed Exchange QRYPTOS to list FarmaTrust FTT Tokens

August 10th, 2018 at 11:37 pm UTC · 3 min read

Qryptos is the cryptocurrency exchange and trading platform of QUOINE. The specific date of listing is to be finalised but it will be shortly after all due diligence is finished, following the successful completion of FarmaTrust’s TDE on 31st July 2018.

QRYPTOS Features

  • Top Class Security: The exchange utilizes multi-factor authentication, dedicated private servers, and bitcoin multi-sig wallets where funds are placed in offline cold storage.
  • Robust API: QRYPTOS has an open API that allows access to the key features of the platform.
  • Crisp Trades: QUOINE’s matching engine is capable of processing nearly one million transactions every second, providing a responsive user experience when placing orders
  • Analytics: QRYPTOS provides users with free charting trend indicators, live charts, and essential charting tools.

The Main Users of the QRYPTOS Website, by Traffic, Come From:

  • USA
  • Indonesia
  • Vietnam
  • India
  • United Kingdom

Raja Sharif, CEO of FarmaTrust Stated;

“Being listed on the right exchanges is fundamentally important to the people and institutions that have participated in the successful FarmaTrust TDE. We are thrilled that an exchange with the pedigree and reach of QRYPTOS has agreed to list the FTT Token. We are particularly pleased to have cemented the relationship with QUOINE as they are regulated by their financial services authority. FarmaTrust has gone through a similarly rigorous process of validation using FCA regulated BlueWater Capital in the UK.”


QUOINE is a leading global fintech company that provides trading, exchange, and next-generation financial services powered by blockchain technology. With offices in Japan, Singapore and Vietnam, QUOINE combines a strong network of local partners with extensive team experience in banking and financial products to deliver best in class financial services for its customers.

In 2014, QUOINE launched Quoine Exchange, now known as QUOINEX, which became one of the largest bitcoin exchanges in the world by transaction volume. QUOINE offers powerful trading features, a sophisticated user dashboard, and secure regulatory compliance to individual and corporate customers.

QUOINEX provides trading services for major cryptocurrencies such as Bitcoin and Ethereum against fiat currency pairs in Japanese yen, US dollar, Euro, HK dollar, Indonesian rupiah, Singapore dollar, Philippine peso, and Australian dollar. QUOINEX has exceeded 55 billion USD in transactions in the past year.

In November 2017, QUOINE successfully raised 350M QASH (the equivalent of 350K ETH or 105M USD) in a token sale at https://liquid.plus, to fund the growth of the LIQUID platform.

In October 2017, QUOINE became the first licensed global cryptocurrency exchange in Japan to launch a global token sale.

QUOINE Corporation was officially licensed by the Japan FSA on 29th September 2017.

In June 2017, QUOINE launched a fully digital cryptocurrency exchange and trading platform called QRYPTOS, exclusively for cryptocurrency trading on the desktop version at www.qryptos.com.

About FarmaTrust

FarmaTrust is the most efficient global pharmaceutical tracking system, ensuring that counterfeit drugs do not enter the supply chain and providing security to pharmaceutical companies, governments, regulators and the public.

FarmaTrust’s blockchain based system utilises Artificial Intelligence, Machine Learning, and big data analysis to deliver value added services, efficiency, and a transparent supply chain. The FarmaTrust system is safe, secure, encrypted, immutable and future proof. FarmaTrust is based in London, United Kingdom.


Katherine Ng

[email protected]

Disclaimer: QRYPTOS is the source of this content. Virtual currency is not legal tender, is not backed by the government, and accounts and value balances are not subject to consumer protections. Cryptocurrencies and tokens are extremely volatile. There is no guarantee of a stable value, or of any value at all.